The Objective Severity Assessment of Atopic Dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis

被引:44
作者
Angelova-Fischer, I
Bauer, A
Hipler, UC
Petrov, I
Kazandjieva, J
Bruckner, T
Diepgen, T
Tsankov, N
Williams, M
Fischer, TW
Elsner, P
Fluhr, JW [1 ]
机构
[1] Univ Med, Dept Dermatol, Sofia, Bulgaria
[2] Univ Jena, Dept Dermatol & Allergol, D-07740 Jena, Germany
[3] Heidelberg Univ, Ctr Occupat Environm Dermatol, D-6900 Heidelberg, Germany
[4] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Paediat, San Francisco, CA 94143 USA
关键词
atopic dermatitis; OSAAD; severity score; reliability; validity;
D O I
10.1111/j.1365-2133.2005.06697.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background The Objective Severity Assessment of Atopic Dermatitis (OSAAD) score is a recently developed scale for evaluation of severity of atopic dermatitis, constructed from the assessment of epidermal barrier function, and properties using noninvasive bioengineering methods and computer-assisted estimates of disease extent. The method has been validated for use in infants and children with atopic dermatitis and compared with a referent scoring system. Objectives The aim of the present study was to test the validity, reliability and sensitivity of the OSAAD score as an objective tool for the assessment of the severity of atopic dermatitis in adult patients. Methods Thirty-two adult patients with atopic dermatitis were included in the study. To assess the validity of the OSAAD score we tested it against the Severity Scoring of Atopic Dermatitis (SCORAD) index of the European Task Force on Atopic Dermatitis as a referent clinical severity scale, and the serum levels of interleukin (IL)-16 as a laboratory variable for monitoring the activity of atopic dermatitis. Responsiveness to change was assessed in a longitudinal study comparing OSAAD, SCORAD and serum levels of IL-16 before and after treatment. To test the reliability of the OSAAD score we studied the interobserver variability of the score recorded by three independent board-certified dermatologists in 16 patients and compared it with SCORAD. Results We report a significant correlation between the OSAAD and the SCORAD index as an acknowledged referent severity scale. The OSAAD score correlated significantly with the serum levels of IL-16 in the acute stage of atopic dermatitis. In a longitudinal study, the OSAAD score decreased significantly, parallel with improvement of the skin findings and a significant decrease in the SCORAD score and IL-16 serum levels. We report improved interobserver variability for the OSAAD score compared with SCORAD. Conclusions: This is the first study validating the OSAAD score as a sensitive and reliable tool for the assessment of the severity of atopic dermatitis in adult patients.
引用
收藏
页码:767 / 773
页数:7
相关论文
共 28 条
[1]   IMPROVEMENT OF SKIN BARRIER FUNCTION DURING TREATMENT OF ATOPIC-DERMATITIS [J].
AALTOKORTE, K .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 33 (06) :969-972
[2]  
BERARDESCA E, 1990, ACTA DERM-VENEREOL, V70, P400
[3]  
Berardesca E, 1997, Skin Res Technol, V3, P126, DOI 10.1111/j.1600-0846.1997.tb00174.x
[4]   Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: Changes in barrier function provide a sensitive indicator of disease activity [J].
Chamlin, SL ;
Kao, J ;
Frieden, IJ ;
Sheu, MY ;
Fowler, AJ ;
Fluhr, JW ;
Williams, ML ;
Elias, PM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (02) :198-208
[5]   Outcome measures of disease severity in atopic eczema [J].
Charman, C ;
Williams, H .
ARCHIVES OF DERMATOLOGY, 2000, 136 (06) :763-769
[6]   Measuring atopic dermatitis severity in randomized controlled clinical trials: What exactly are we measuring? [J].
Charman, C ;
Chambers, C ;
Williams, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (06) :932-941
[7]  
Charman CR, 1999, BRIT J DERMATOL, V140, P109
[8]   Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness [J].
Diepgen, TL ;
Sauerbrei, W ;
Fartasch, M .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (09) :1031-1038
[9]  
Eberlein-König B, 2000, ACTA DERM-VENEREOL, V80, P188
[10]  
ELSNER P, 1994, BIOENGINEERING SKIN